Cancer Drugs Cancer
cancer cells
anti-cancer effect
cancer site
anti-cancer therapy
anti-cancer drug Doxil
approved anti-cancer drugs
cancer animal models
upgrade existing anti-cancer drugs
human cancer cell lines
shielded drug
DeShield technology
DeShield project
side-effects
therapeutic effect
business expertise
proof of concept
body
novel approach
high expertise
business strategy
de-shielding
ERC-funded research
comprehensive market research
conductance of preclinical animal studies
successful valorization
way
clinical trials
morbidity
mortality
attractive commercial proposition
development
complementary areas
healthy parts
team
prominent causes
industrialized countries
external stimulus
key challenge
order
technical advance
functionality